MRI High-Intensity Signals in Late-Life Depression and Alzheimer's Disease: A Comparison of Subjects Without Major Vascular Risk Factors

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
David S MillerG Gottlieb

Abstract

The authors examined periventricular white matter, deep white matter, and subcortical magnetic resonance imaging (MRI) high-intensity signals in subjects with late-life depression, probable Alzheimer's disease (DAT), and healthy, age-matched controls. All subjects were healthy and free of major vascular risk factors, including hypertension. MRIs were performed using a 1.5-tesla GE Signa scanner. T2 and proton-density-weighted images were analyzed by a neuroradiologist blind to the clinical status of all subjects. There were no statistically significant differences on any of the MRI indices between the groups studied. These data demonstrate that late-life depression, like DAT, in the absence of major vascular risk factors, is not associated with a significant increase in MRI high-intensity signals when compared to healthy, control subjects.

Citations

Feb 18, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·I SchweitzerJ O'Brien
Oct 31, 2002·International Journal of Geriatric Psychiatry·Isaac SchweitzerDavid Ames
Sep 20, 1997·Acta Psychiatrica Scandinavica·P Videbech
May 9, 2012·Current Psychiatry Reports·Brianne M Disabato, Yvette I Sheline
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Robert C Baldwin, John O'Brien
Apr 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·J O'BrienB Tress
Feb 18, 2020·Current Alzheimer Research·Agnieszka BrzezińskaJakub Kaźmierski
Sep 1, 1996·Psychosomatic Medicine·I LesserK M Lin
Jul 6, 2011·Archives of General Psychiatry·Matthew J KemptonSteven C R Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

© 2022 Meta ULC. All rights reserved